During the COVID-19 pandemic, the Department of Health and Human Services (HHS) waived or modified health regulations to better equip hospitals, primary care clinics and other care settings to help prevent and treat cases of COVID-19. Many of these waivers were tied to the Public Health Emergency (PHE), which is set to expire on May 11, 2023.

On April 12, VHAN held a Town Hall to discuss the implications of unwinding from the PHE, as well as ways you can adjust to these changes and sustain quality patient care with minimal interruptions. Read the full article for key takeaways and additional resources that can help you with the PHE expiration.

Signed into law in August 2022, the Inflation Reduction Act (IRA) includes provisions to lower health care and medication costs over the next several years. This article outlines a few key implications of which providers should be aware.

The way we practiced health care a decade ago is barely recognizable today. But VHAN has successfully navigated this sea change over the past 10 years by keeping our eye on what matters most—improved care delivery, better outcomes and true health equity.

In recent years the VHAN Population Health Pharmacy Team has made it a priority to help patients, particularly ones with chronic illnesses, improve compliance to their prescriptions. This focus on medication adherence not only helps patients better manage their chronic diseases, but it also helps maintain consistent medical care during transitions and even reduce drug costs. It’s all part of the team’s efforts to produce better patient outcomes.

In recent months, demand for GLP1 (glucagon like peptide 1) receptor agonists has skyrocketed across the country, leaving providers inundated with prescription requests and patients frustrated with shortages. GLP1 agonists have an important place in obesity therapy. However, there are many unanswered questions about long-term side effects, cost-effectiveness and the duration of therapy. Unfortunately, current manufacturing cannot adequately meet the demand for both diabetes and obesity treatment. The VHAN Pharmacy Team has the following recommendations for navigating ongoing shortages.

One of our key goals has been to develop a systematic approach to identify and review utilization patterns, trends and variation in care that impact quality outcomes and costs across VHAN.

Last month the Biden-Harris administration announced that the COVID-19 Public Health Emergency (PHE) will end on May 11. This will have large impacts on Medicare ACO programs as well as TennCare recipients. Read the full article for a few items that members should be aware of.

In May 2022, VHAN established a new acute care outreach team for Connected Care of Middle Tennessee Medicare ACO patients.

This year VHAN will distribute $17.7 million in shared savings and performance bonuses from Health Plans, Aetna, Aetna MA, United Healthcare and Humana contracts, thanks to our members’ outstanding performance in 2021.